devinitorg/iati-policy-markers huggingface dataset:
Chinasoft Project Chinasoft International Limited (Chinasoft or the company) is a Chinese IT services firm providing solutions and software to the domestic market, with a particular focus on government and state-linked customers.  The companys clients include the State Bureau of Auditing, the General Administration of Quality Supervision, Inspection & Quarantine, the State Tobacco Control Bureau and the six largest Economic Technology Development Areas (ETDAs) in China.  Chinasoft is headquartered in Beijing with branch offices and delivery centers in six cities.  

The company was established in April 2000, when 20 key management staff left China National Software & Technology Service Corporation (CS&S) to start the company.  CS&S is a 42% state-owned enterprise (SOE) that is regarded as one of the countrys best established software companies and is listed on the Shanghai stock exchange.  Chinasoft was publicly listed on the Hong Kong Stock Exchanges Growth Enterprise Market (HK GEM) in June 2003.  For the year ended December 31, 2004, Chinasoft generated revenues of $35.5 million, EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of $5.5 million and net income of $4.3 million.
Asia Heart Project Hong Kong Asia Medical Holding Co., Ltd (Asia Medical or the Company) is a holding company registered in Hong Kong SAR, China, that engages in the hospital business and hotel management. Through Wuhan Asia Industrial Co., Ltd (Asia Industrial), a wholly owned foreign enterprise (WOFE) registered in China, Asia Medical holds four hospitals (collectively Asia Heart or the Hospital Group), including Wuhan Asia Heart Hospital (WAH or the Hospital) , which is the flagship cardiovascular hospital founded in 1999, Asia Heart Xinjiang Hospital (Xinjiang Hospital) which was acquired in 2010, Asia Heart No.7 Hospital (No.7 Hospital) which is the state-owned hospital managed by WAH on a 25-year management contract starting from Feb 2011, and Asia Heart Jiangcheng Hospital (Jiangcheng Hospital or the Project), which is the 1,850-bed greenfield hospital expected to open in 2016.   IFC will provide US$35 million financing to Asia Medical to support the construction of Jiangcheng Hospital. 1. Support of private healthcare provider in frontier region: The Project will channel the much-needed private sector capital to finance a new hospital in the frontier region where patients may have better access to quality healthcare services.  2. Sharing of best practices: Best management and clinical practices will be transferred from Asia Heart''s operations to the newly acquired hospitals and the greenfield hospital, hence raising the quality of healthcare services in the country.  3. Employment generation: The expansionary aspects of this project will provide employment opportunities to healthcare workers in China. 4. Promoting healthcare reform: Despite the recent lift on restrictions over private investment in healthcare sector, the Chinese health authorities are still cautious due to negative publicity about private hospitals and the lack of successful examples. The ongoing success of Asia Heart may improve health authorities'' confidence in private healthcare providers and may further promote private players to enter the sector.
Di'An Diagnostics The proposed investment will support DiAn Diagnostics Group Co., Ltd. (DiAn, the Company or the Borrower) to (i) expand and upgrade its existing ICL network and create 5 regional test centers through expansion of existing ICLs; (ii) add 5 spoke ICLs in second/third tier cities; (iii) build a manufacturing center for its self-developed In Vitro Diagnostic (IVD) products; (iv) fund R&D expenses to accelerate expansion in specialized testing and (v) build advanced IT infrastructure and data analytics function over the next five years (together, the Project). The additional testing capacity created by the Project will help to relieve capacity constraints at over-crowded public hospitals while expanding the types of testing available. Stakeholders: The most significant project outcome is the increased provision of quality and affordable diagnostics services in China. The Project also aims at relieving the overcapacity issue at tertiary hospitals in China while enhancing the testing service offerings at secondary and primary hospitals.

Resilience: The Project will help increase overall testing capabilities and hopefully have a spillover effect in terms of building resilience against future pandemics in emerging markets around the world.

Market Impact: The key market impact is the facilitation of reduction in prices of critical healthcare diagnoses through centralization and increased throughput and efficiency of lab testing. The project will lead to better quality and more accessible tests to the general public as well as demonstration effect to increase the number of market participants.
CGCCD Project Chengdu Small Enterprise Credit Guarantee Company Limited (Chengdu CGC) was established in 2001 with a mandate of helping SMEs access finance.  Chengdu CGC was initially funded by Chengdu municipal government and UK government through a donation.  The State Secretariat for Economic Affairs of Switzerland (SECO) took an equity stake in Chengdu CGC in 2004.  The IFC has been providing technical assistance and other training programs to Chengdu CGC since 2002.    CGCs main business is to provide partial guarantee on loans extended by local banks to SMEs in Chengdu metropolitan area.  Its target clients are those who otherwise meet banks lending criteria but are unable to provide sufficient collateral as normally required by local banks.  Over the past six years, CGC has provided loan guarantees amounting to RMB6.2 billion ($887 million), creating or maintaining employments for at least 60,000 people.  At present, the company has about 780 SME clients and more than 1000 individual clients (e.g., unincorporated small businesses).      The purpose of the project is to help SMEs in the greater Chengdu metropolitan area get much needed financing to restore and/or expand their production and operation capacity in the aftermath of recent earthquake in Sichuan Province, China.  Three satellite cities in Chengdu metropolitan area, Dujiangyan, Pengzhou and Chongzhou, were among the hardest hit cities by the earthquake. The project will form a part of outpouring of international support to the earthquake hit Sichuan Province.  It is expected to be one of the first commercial-based initiatives focusing on restoring private sector capacity, with most beneficiaries being SMEs.
MicroCred Parallel Facility - Nanchong MicroCred Nanchong is a greenfield microfinance institution (MFI).  It will propose a range of products from micro-loans for micro-enterprises to loans for small and medium-sized enterprises (SMEs).  It will target local entrepreneurs with limited access to formal financial services in China.  It will focus its activities around the city of Nanchong, in the Sichuan province of China.  MicroCred Nanchong will be managed by local and international staff with prior experience in micro and small business lending.  It will also be supported by technical assistance from MicroCred S.A. (MicroCred Holding). The developmental impact of MicroCred Nanchong is expected to be far reaching in terms of its economic support for productive micro-entrepreneurs, small businesses and SMEs, employment generation and providing access to finance to an underserved segment of the market.
CDH Venture Fund The project is a proposed equity investment of up to $20 million in CDH Venture Partners, L.P. (CDH Venture or the Fund), a 10-year closed-end venture capital fund that will invest in fast growing early-stage Chinese companies in varied industry sectors.  CDH Venture is the third fund sponsored by CDH China Management Company Limited (CDH), a leading domestic private equity fund manager in China.  IFC has invested in CDHs previous two growth capital funds. CDH Venture is expected to deliver significant development impacts in China in terms of financial returns, economic growth, private sector development, and environmental & social compliances.
Nanjing City Commercial Bank This proposed project is to provide an RMB loan of up to RMB 400 million (approximately $50 million equivalent) to Nanjing City Commercial Bank (NCCB) to support its lending to local SME clients and help improve its asset-liability maturity matching. The IFC loan will be funded by part of the proceeds from the second tranche of IFCs RMB Bond (Panda Bond II) which is expected to be issued in November 2006.   IFC would also provide a technical assistance program to NCCB to support its SME lending business. The proposed project is expected to have very positive impacts on Chinas financial market and economic development.   The SME sector, mostly privately owned, provides a significant proportion of employment of the country. A growing and robust SME sector is critical to help accelerate Chinas transition to a market economy. However due to the small scale of the SMEs, this sector has always been under served by banks which provide over 90% of funding to the economy. Among all the difficulties, lack of access to banks financing is always cited as the top challenge faced by SMEs. The proposed RMB loan under this project will be the first IFC loan to a local Chinese bank to support its SME lending. It will act as a catalyst to help mobilize more banks resources in SME business and hence to increase the accessibility of local SMEs to banks financial services.  The proposed IFC loan combined with a technical assistance program will not only provide NCCB with the long term funding, but also help the bank develop an end-to-end process and methodology in terms of customer identification, risk-based pricing, system and product development, etc. If executed successfully the program can be potentially rolled out to other banks that have similar demand of NCCB. In light of this, the project will help to bring and establish the best SME lending practice for smaller Chinese banks and hence promote healthy growth of the banking sector as a whole.
BVCF III, LP IFC is proposing an equity investment in BVCF III, L.P. (the Fund), a private equity fund focusing on growth-stage Life Sciences and Healthcare companies in China.  The Fund will make equity investments in early- and growth-stage companies in a range of sectors, including pharmaceuticals, biotechnology, traditional Chinese medicine (TCM), medical technology, healthcare services, and industrial and environmental biotechnology. The Fund is expected to deliver strong development impact as it would: (i) help the companies it invests in grow faster and more sustainable, through hands-on managerial and operational involvement, than they would otherwise do; (ii) support the job creation of the fast-growing healthcare companies, including woman employment; (iii) help ensure implementation of best practice governance, including the IFC Environmental and Social (E&S) Standards, in the Fund's investee companies; and (iv) facilitate the transfer of important knowledge and skills to local entrepreneurs that will improve their competitiveness in the global marketplace.
Suzhou Huasu Plastics Company, Ltd. Summary Of Project Information (SPI)       Project Name    China-Suzhou PVC Project               Region    Asia        Sector       Project No008213   Projected Board DateApril 22, 1997   Company NameSuzhou Huasu Plastics Co., Ltd.   Technical Partner and/or Major Shareholders    	Westlake International Investments Corp.  (BVI):    43%                 Norsk Hydro a.s. (Norway):                          32%                 China Jiangsu Chemical Pesticide Group Co. (China): 14%                 China Taicang Petrochemical Co. (China):             3%    Project Cost Including proposed IFC investment    	The estimated cost of the Revised Project is about US$90 million.    Location of project and Description of site    	Taicang Economic Development Area in Suzhou City (Jiangsu Province), about 40 km northwest of Shanghai    Description of Company and Purpose of Project    	In February 1995, IFCs Board approved financing for the Project in its initial scope which was to construct and operate a 60,000 metric tons per year (tpy) polyvinyl chloride (PVC) resin plant and a 24,000 tpy PVC film calendering facility. Since then, the project scope has been modified to provide a larger PVC resin capacity in view of an expanding market.  In its revised scope, the Revised Project is to construct and operate a 100,000 tpy PVC resin plant and a 24,000 tpy PVC film calendering facility.  The calendering facility has been operational since 1995, while the PVC resin plant is expected to be completed in 1999.  The plants will use technology owned and developed by the Westlake Group of the U.S..  PVC is a major thermoplastic with wide applications in industrial and consumer products such as pipes, fittings, wire cables and bottles.      Environmental Category and Issues    	This is a category B project according to IFCs environmental review procedures.  The following potential environmental, health and safety impacts of this project were analyzed: site location and infrastructure, air emissions, liquid effluent management, solid waste, environmental and safety standards applied, and emergency prevention and response.  The plant design is based on U.S. engineering specifications for environment and safety and the project is designed to comply with local regulations and World Bank guidelines.  The Environmental Protection Bureau of Suzhou City has approved the Environmental Impact Assessment Reports submitted by the Company.    The  is  from the Public Information Center.       Date SPI sent to PIC     March 10, 1997      For Additional Information contact:  Corporate Relations Unit -   telephone: (202) 473-7711   facsimile: (202) 676-0365  Environmental documents for this project are available at http://www.ifc.org and from the World Bank InfoShop (http://www.worldbank.org/html/pic/aboutinfo.html).
Bank of Shanghai Summary Of Project Information (SPI)       Project Name:    China - Bank of Shanghai      Region:East Asia and Pacific   Sector:   Project No:007160   Projected Board Date:June 10th, 1999   Company Name:Bank of Shanghai   Technical Partner and/or Major Shareholders    	The shareholders of BOS consist of (i) the Municipal Government and District Governments of Shanghai Municipality; (ii) large state-owned enterprises in Shanghai; (iii) collective and private enterprises; and (iv) individuals, including employees of BOS.    Project Cost Including proposed IFC investment    	The proposed IFC investment is estimated to be about US$20 million, representing an equity stake in BOS.    Location of project and Description of site    	Shanghai, China    Description of Company and Purpose of Project   (include IFCs Role and Development Impact)    	Established in December 1995 through a merger of 99 existing urban credit cooperatives, BOS is a full-service commercial bank operating in Shanghai City.  Its principal operational mandate is to support the non-state sector of Shanghai, namely, small and medium-sized enterprises which are collectively and privately owned.    IFC has been playing, and is expected to continue to play, an important role in this project.  The primary objective of IFC''s involvement with BOS is to assist BOS in its transformation into a well-managed modern commercial bank for emulation by other banks in China. IFC has since 1995 been implementing a long-term, comprehensive technical assistance program with BOS in the form of a "bank twinning" arrangement.  The program has been funded by the EC and Japan Trust Funds, and the foreign technical partner is ABN AMRO.      This project entails a strong development Impact.  Through supporting BOS, IFC will be assisting (i) the Chinese Government in its effort to introduce international banking standards and practices in China''s banking sector; and (ii) the development of the non-state and private sector in Shanghai.    Environmental Category and Issues    	This is a Financial Intermediary (FI) Type 1 project according to IFC''s environmental review procedure.  For relevant operations, BOS will be required to undertake an environmental review of eligible borrowers'' environmental performance and each sub-project''s compliance with the Chinese environmental, health and safety laws, regulations and standards.    IFC will assess BOSs capability to carry out environmental reviews.   BOS will be required to submit to IFC an Annual Environmental Performance Report.     The  is  from the Public Information Center.       Date SPI sent to PIC     May 10th 1999      This Summary of Project Information is prepared and distributed to the public in advance of consideration of the proposed transaction by the Corporations Board of Directors.  It is provided for the purpose of enhancing the transparency of IFCs activities and should not be construed as presuming the outcome of IFC Board consideration.    For Additional Information contact:  Corporate Relations Unit -   telephone: (202) 473-7711   facsimile: (202) 974-4384
Asia Environmental Partners, L.P. Asia Environmental Partners, L.P (AEP or the Fund) is a US$250 million equity fund placed by Olympus Capital Holdings Asia (Olympus Capital or Sponsor), a pan-Asian middle-market private equity firm, to make equity and equity-related investments in renewable energy / environmental services companies in Asia.  The Fund will target ten to twelve opportunities in the $20-50 million range, in clean energy (energy efficiency, clean energy distribution infrastructure, renewable energy projects), clean technologies, waste management (solid waste management, waste water treatment), water quality treatment infrastructure, and pollution control. The project is expected to have quantifiable impact on growing private enterprises involved in the clean energy sectors in Asia, on development of the clean energy sector in general, and on mitigation of climate change; all of which will be monitored by IFC using a set of quantifiable climate change impact indicators throughout the life of the Fund.  Equally important are the non-quantifiable development impacts expected from the proposed investment, i.e.,

 - commercialization of innovative environmental technologies and business models; 
- promotion of more efficient and sustainable growth in Asia; and
- improvement of environment and quality of life for the people of Asia.
Maple Leaf Edu China Maple Leaf Educational Systems Limited (Maple Leaf or the Company) operates the largest international school network in China, comprising over 13,500 students across 33 schools in eight cities located in China namely Dalian, Tianjin, Wuhan, Chongqing, Ordos, Luoyang, Shanghai and Zhenjiang. The Company offers a differentiated bilingual, dual-curriculum and dual-diploma programs. Maple Leaf is incorporated in the Cayman Islands and its operating subsidiaries are located in the Peoples Republic of China.  The project under consideration is for the expansion of private K-12 school operations by Maple Leaf in China.  To fund this growth, the Company is planning to raise US$100-150 million in an Initial Public Offering (IPO) currently scheduled for November 2014. (i) improving access of bilingual education in Tier II, Tier III and Tier IV cities in China, (ii) demonstration effect regarding the viability of moderately priced bilingual international education and (iii) contribution to employability of Chinese students in the long term.
Yi Ming China Fund The Yi Ming China Fund I L.P. (Yi Ming Fund or the Fund) is a seven-year generalist private equity (PE) fund focused on control and growth capital investments in SMEs in China. The Fund seeks to invest along the core themes of the development of Chinas inland regions (Western China) and the development of Chinas agribusiness, food, beverage and healthcare sectors. The Fund is raised by CMIA Capital Partners (CMIA or the Manager). Expected development impact includes (i) promoting sustainable private sector growth by mobilizing capital to SMEs in the developing Western China region, (ii) helping to improve productivity, operational efficiencies, and quality control across its portfolio companies and (iii) improving environment, safety and health standards through sustainable practices.
Chenming LWC The project is a $487 million investment in Jiangxi Chenming a greenfield paper facility in the Changbei economic development zone, Nanchang city, China. The facility will produce 350,000 tpy of light weight coated (LWC) paper and will be built and operated by Shandong Chenming Paper Holdings (Chenming or the sponsor), the largest Chinese-owned paper company, and Shinmoorim Paper MFG Company (Shinmoorim), South Koreas second largest coated paper producer and IFC client.  The project will be implemented over an 18 month period and consist of:   -  installation and operation of an LWC paper machine with an annual capacity of 350,000 metric tons per annum (tpy);  -  a Bleached Thermo Mechanical Pulp (BTMP) plant with an annual capacity of 187,000 tpy;  -  a De-Inked Pulp (DIP) plant with an annual capacity of 136,000 tpy;  -  a co-generation power plant with a total capacity of 100 megawatts; and  -  ancillary infrastructure, including wastewater treatment and port installations.  This purpose of this project is to support Chenmings strategy of becoming a major international paper company within the next five years and it will also facilitate Shinmoorims expansion in China.  In so doing, it will bridge a market gap in the availability of LWC paper in the Asia-Pacific region, which is a limited producer and net importer of coated paper.  Given that market trends indicate an increasing demand for LWC paper, local Chinese production of this light-weight paper will reduce costs for end-users, especially those in advertising and print media.
BRCB Project The proposed project entails an equity investment by IFC for an equity stake of 10% in Tianjin Binbai Rural Commercial Bank (BRCB), a new rural commercial bank to be formed through the consolidation of three rural credit cooperative unions (RCCUs) in the Binhai New Economic Zone of Tianjin.  The investment will be accompanied by a technical assistance program to BRCB. This project will signify IFCs continued support of the reform and restructuring of Chinas rural banking system. The project will likely create a strong demonstration impact through improved corporate governance, risk management and stronger operating performance resulting from the introduction of international practices.   The success of the project will establish a replicable model for reforming the struggling rural credit cooperatives into commercially sustainable rural commercial banks.
Jointown Pharma Jointown Pharmaceutical Group Co., Ltd. (Jointown or the Company) is a major pharmaceutical product distribution company founded in 1999 in China with its headquarter based in Wuhan province and is publicly listed on the Stock Exchange of Shanghai (600998 SHA), with 31 provincial level and 94 prefecture level product distribution and logistics centers throughout China. The Company procures pharmaceutical products and small medical devices, stores in its large network of logistical centers in China, to be subsequently sold to hospitals, clinics, and pharmacies throughout China, transported through its own 1700-strong truck fleet, and via 85 third-party truck fleet companies throughout China contracted by the company on an as-needed basis. IFC is looking to support Jointowns expansion, which comprises of the construction of up to 5 new product distribution centers and upgrading of 4 existing warehouses in Middle and Western China (the Project). The Project will increase access to a wider choice of more affordable essential drugs patients in rural and frontier regions in Middle and Western China. The Project will also create 5,000 new direct jobs at the new facilities.  As a result of the Project, the Company is expected to increase procurement from SME suppliers thereby creating additional indirect employment opportunities.